Intestinal spasmolytic effects of STW 5 (Iberogast) and its components.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Phytomedicine

• Publication date

  2006-11-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PHYMED.2006.03.013PMID 16709451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.

  2006cited by this paper
• Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.

  2006cited by this paper
• STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.

  2006cited by this paper
• Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.

  2006cited by this paper
• Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 ( Iberogast s )

  2006cited by this paper
• Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast).

  2006cited by this paper
• STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.

  2006cited by this paper
• Functional dyspepsia--a multicausal disease and its therapy.

  2006influential reference
• Binding of STW 5 ( Iberogast s ) and its components to intestinal 5-HT , muscarinic M 3 , and opioid receptors

  2006cited by this paper
• Pathophysiology and treatment of functional dyspepsia.

  2005cited by this paper
• Functional dyspepsia

  2004cited by this paper
• Meta‐analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)

  2004cited by this paper
• Review article: the overlap between functional dyspepsia and irritable bowel syndrome — a tale of one or two disorders?

  2004cited by this paper
• Mechanisms of the contractile effect of the alcoholic extract of Aegle marmelos Corr. on isolated guinea pig ileum and tracheal chain.

  2004cited by this paper
• Efficacy of a herbal preparation in patients with functional dyspepsia: A meta-analysis of double-blind, randomized, clinical trials

  2003cited by this paper
• Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine?

  2003cited by this paper
• Irritable bowel syndrome: disease definition and symptom description.

  1998cited by this paper
• Spasmolytic activity of medicinal plants used for the treatment of disorders involving smooth muscles.

  1996cited by this paper
• Ca2+ entry and vasoconstriction during osmotic swelling of vascular smooth muscle cells

  1995cited by this paper
• The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver.

  1995cited by this paper
• GASTROINTESTINAL MOTILITY MODULATION WITH IBEROGAST

  1993cited by this paper
• Hydroxycinnamic Acid Derivatives, Caffeoylmalic and New Caffeoylaldonic Acid Esters, from Chelidonium majus*,1

  1993cited by this paper
• Inhibition of Intestinal Motility and Secretion by Flavonoids in Mice and Rats: Structure‐activity Relationships

  1993cited by this paper
• Pathophysiology and treatment of functional dyspepsia.

  1993cited by this paper
• Dyspepsia and dyspepsia subgroups: a population-based study.

  1992cited by this paper
• Isolation and Testing of the Calcium Blocking Activity of Furanocoumarins from Angelica archangelica

  1991cited by this paper
• Licorice, more than just a flavour

  1986cited by this paper
• Relaxant effects on tracheal and ileal smooth muscles of the guinea pig.

  1985cited by this paper
• Antispasmodic Effects of Some Medicinal Plants

  1980cited by this paper
• [Effect of silymarin on osmotic resistance of erythrocytes].

  1971cited by this paper

• Effect of STW 5‐II (Iberogast‐N) on Tolerance to Gastric Gas in Patients With Functional Dyspepsia. The IBO‐2 Study

  2025cites this paper
• Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double‐blind, placebo control clinical trial

  2024cites this paper
• Herbal Amara extract induces gastric fundus relaxation via inhibition of the M2 muscarinic receptor

  2024cites this paper
• Chemical Compositions and Pharmacological Activities of Iberis amara L. (A Review)

  2024cites this paper
• Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells

  2023cites this paper
• Understanding the phytochemistry and molecular insights to the pharmacology of Angelica archangelica L. (garden angelica) and its bioactive components

  2021cites this paper
• Essential oils: a review on their salient biological activities and major delivery strategies

  2020cites this paper
• Chelidonine Selectively Inhibits the Growth of Gefitinib-resistant Non-small Cell Lung Cancer Cells through the EGFR-AMPK Pathway.

  2020cites this paper
• The possibilities of phytotherapy in the treatment of patients with functional disorders of the digestive tract

  2020cites this paper
• Application of an in vitro digestion model to study the metabolic profile changes of an herbal extract combination by UHPLC-HRMS.

  2020cites this paper
• The Effect of Greater Celandine Active Ingredient Chelidonine on Isolated Rat Bladder and Trachea Smooth Muscles and Primary Lung and Kidney Cell Lines

  2020cites this paper
• Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action.

  2020cites this paper
• Antispasmodic Effect of Essential Oils and Their Constituents: A Review

  2019cites this paper
• Basal and Spasmolytic Effects of a Hydroethanolic Leaf Extract of Melissa officinalis L. on Intestinal Motility: An Ex Vivo Study

  2019cites this paper
• Design, synthesis and apoptosis-related antiproliferative activities of chelidonine derivatives.

  2019cites this paper
• Synergy quantifications to identify individual contributions of combination partners to the overall activity - The example of STW 5.

  2019cites this paper
• The Enhancing Effect of Chamomile on Histological and Immunohistochemical Alterations in Diabetic Rats

  2019cites this paper
• Evidencia clínica de STW 5 (Iberogast®) en patología digestiva

  2018cites this paper
• Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target

  2018cites this paper
• Chelidonine inhibits TNF‐α‐induced inflammation by suppressing the NF‐κB pathways in HCT116 cells

  2018cites this paper
• Pharmacokinetic interactions: the effect of herbal extracts and supplements on drug permeation

  2018cites this paper
• Mechanism‐based inactivation of cytochrome P450 2D6 by chelidonine

  2018cites this paper
• Modulation of gastrointestinal motility beyond metoclopramide and domperidone

  2017cites this paper
• Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders

  2017cites this paper
• Hydro-alcoholic extract of Matricaria recutita exhibited dual anti-spasmodic effect via modulation of Ca2+ channels, NO and PKA2-kinase pathway in rabbit jejunum

  2017cites this paper
• Chelidonine and Homochelidonine Induce Cell Death through Cell Cycle Checkpoints and MAP Kinase Pathways

  2017cites this paper
• Ergebnisse universitärer Forschung in der Naturheilkunde: Klinische Phytotherapie

  2017cites this paper
• Chelidonine induces mitotic slippage and apoptotic-like death in SGC-7901 human gastric carcinoma cells.

  2016cites this paper
• Isolation and evaluation of the myorelaxant effect of bergapten on isolated rat jejunum

  2016influential citation
• Medicinal plants – prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review

  2016cites this paper
• The Pharmacological Effects of Benachio-F® on Rat Gastrointestinal Functions

  2015cites this paper
• [Integrative medicine in the management of functional dyspepsia. Role of the herbal preparation STW5].

  2014cites this paper
• Action mechanism of the monoterpenes (+)-pulegone and 4-terpinyl acetate in isolated guinea pig ileum

  2013cites this paper
• Chelidonium majus and its effects on uterine contractility in a perfusion model.

  2013cites this paper
• Antidiabetic Effects of Chamomile Flowers Extract in Obese Mice through Transcriptional Stimulation of Nutrient Sensors of the Peroxisome Proliferator-Activated Receptor (PPAR) Family

  2013cites this paper
• Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation

  2012cites this paper
• Adenosine Receptors: New Targets to Protect Against Tissue Damage in Inflammatory Bowel Symptoms

  2012cites this paper
• ROLE OF HISTAMINEGIC AND CALCIUM CHANNELS IN THE INHIBITORY EFFECTS OF HYDROALCOHOLIC EXTRACT OF MATRICARIA RECUTITA L. ON ISOLATED RABBIT JEJUNUM

  2011cites this paper
• Oxidativer Stress und Mastzellen: Ansatzmöglichkeiten bei der Phytotherapie des Reizdarmsyndroms?

  2011cites this paper
• Spasmolytic Botanicals: Relaxing Smooth Muscle with Herbs

  2011cites this paper
• Effect of commonly consumed botanicals on drug efflux across intestinal epithelial cells and excised tissues.

  2011cites this paper
• Spasmolytic activity of p-menthane esters

  2011cites this paper
• Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations

  2011cites this paper
• Herb–drug pharmacokinetic interactions reviewed

  2010cites this paper
• The Chemical and Biological Properties of Protopine and Allocryptopine

  2010cites this paper
• Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6.

  2009cites this paper
• The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis

  2009cites this paper
• STW 5/Iberogast: Multi-Target-Wirkung bei funktioneller Dyspepsie und Reizdarmsyndrom

  2007cites this paper
• [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].

  2007cites this paper
• STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study

  2007cites this paper
• In vitro Untersuchungen zur Wirkung von Phytopharmaka auf die Kontraktilität des Mäuse-Ileums: Mögliche Bedeutung für die Therapie des Reizdarmsyndroms

  2007cites this paper
• The active components and the pharmacological multi-target principle of STW 5 (Iberogast).

  2006cites this paper
• The active components and the pharmacological multi-target principle of STW 5 ( Iberogast s )

  2006cites this paper
• Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.

  2006cites this paper
• Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 ( Iberogast s )

  2006influential citation
• Ex vivo / in vitro absorption of STW 5 ( Iberogast s ) and its extract components

  2006cites this paper
• Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components.

  2006cites this paper
• Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast).

  2006cites this paper
• STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.

  2006cites this paper